COVID-19 Impact on Pharmaceutical Packaging in Chemicals and Materials Industry

COVID-19 Impact on Cold Laser Therapy in the Healthcare Industry

  • Healthcare
  • Jul 28, 2021

OVERVIEW AFTERMATH OF COVID-19 AND GOVERNMENT ROLE

A recent SARS-CoV-2, virus has caused a general pandemic of respiratory disease, called COVID-19. The infection initially showed up in Wuhan, a city in China, in December 2019. The patients experiencing COVID-19 are cautiously dealt with all the safety measures since this sickness spreads quicker through actual contact.

There are now numerous vaccines in use. The first mass vaccination program commenced in early December 2020 and as of 15 February 2021, 175.3 million vaccine doses have been administered.

World Health Organization (WHO) issued an Emergency Use Listing (EULs) for the Pfizer COVID-19 vaccine (BNT162b2) on 31 December 2020, issued another two EULs for two versions of the AstraZeneca/Oxford COVID-19 vaccine, manufactured by the Serum Institute of India and SKBio on 15 February 2021. On 12 March 2021, WHO issued a EUL for the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson, Service Inc.)

As per the WHO report, globally, as of 9 June 2021, 173,674,509 confirmed cases of COVID-19, including 3,744,408 deaths, were reported to WHO. As of 8 June 2021, a total of 2,092,863,229 vaccine doses have been administered.

As per the WHO report, In United States of America, from 3 January 2020, 9 June 2021, there have been 33,056,361 confirmed cases of COVID-19 with 592,610 deaths, reported to WHO. As of 3 June 2021, a total of 301,161,088 vaccine doses have been administered.

Even though immunization is found for COVID-19, safeguards incorporate incessant hand-wash, wearing a face veil, and keeping up social separating.

Different wavelengths and outputs of low-level light are applied directly to a targeted area in the cold laser procedure. The body tissue then absorbs the light. The red and near-infrared light causes a reaction, and the damaged cells respond with a physiological reaction that promotes regeneration.

Doctors, dentists, physical therapists, and other medical professionals use cold laser therapy in numerous ways. The key uses for cold laser therapy are tissue repair and relief from pain and inflammation.

Cold laser therapy is widely used for minor injuries and sprains, inflammation, aches and pains, skin rejuvenation, wound healing, acupuncture.

In light of the fiery impacts of the infection, there are hypothetical dangers that the viral contamination could delay the cold laser therapy and treatments as there have been limited visits to the hospitals and healthcare centers due to the lockdown imposed by the government in different countries.

Impact on Price

Because of COVID-19, the market is upset to a major level; the few foundations need to stay shut while others downsize the activities or pause extension plans as they attempt to endure the uncommon emergency.

The current COVID-19 episode has influenced essentially every industry on earth, and cold laser therapy market is no exemption. There has been a tremendous and sudden lessening in the volume of elective joint substitutions worldwide as wellbeing situation legitimately organize their COVID-19 reaction.

States must develop and implement policies that allow for interstate licensure and practice of medicine (entailing the use of telemedicine) to enable consultation and communication to remote areas and ensure the swift flow of information across state lines.

Now, as the demand for telehealth innovation is turning out to be very demanding by human beings, and this will make the market more competitive due to new and more innovative equipment that will be launched by the makers, by decreasing the overall cost of the new and innovative cold laser therapy products.

Impact On Demand

Since the pandemic, due to the lockdown situation, the economic growth of a country is declining day by day. And the manufacturing units for various items shut down due to the non-availability of workforce.

There will be opportunities in the coming time for manufacturers of digital health technologies to position themselves for the COVID-19 recovery. When COVID-19 responses ease, there will be excess elective surgery procedures in emergency clinics and hospitals. The pre-appointment programs can help smooth out the planning, arrangement, and conveyance of the medical professionals and the doctors.

For instance,

  • A study by Kreisler et al (2004) stated that low-level laser therapy could be beneficial for the reduction of post-operative pain
  • Hemophilia-induced arthropathy due to recurrent joint bleeding leads to physical, psychological, and socioeconomic problems in children. High-intensity laser therapy (HILT) minimized pain, increased functional capacity, and ameliorated gait performance in children with hemophilic arthropathy after only a few treatment sessions
  • Multinational Association for Supportive Care in Cancer (MASCC) guidelines recommend PBM treatment for the prevention of oral mucositis

Cloud-based stages have an extraordinary preferred position in permitting the clinician and their representatives to design cases distantly while travel and medical clinic access limitations are set up. With the careful plans and embeds chose early, embed providers, and emergency clinics have the chance to enhance their stock and creation (on account of patient-explicit custom parts) to address the accumulation of cases once the circumstance permits effectively.

Impact on Supply

Because of the pertinacious COVID-19 lockdown, sanctions have been forced by administrations of different nations. These limitations and boundaries across the nation’s borders prompted a diminishing stockpile because of restricted materials and labor force and halting of the assembly line.

The supply chain units are taking stringent measures and risk mitigation protocols to provide the devices to the manufacturers to the customer. The presence of key market players for the development and launch of the cold laser therapy products will increase the net sales and may show a surplus growth in the market.

Additionally, the manufacturers are also taking crucial steps to ensure the availability of raw materials by and also they have to look into the quality of products. Since the demand is increasing day by day, to meet the demand, the major manufacturers and suppliers are collaborating to ensure the supply of raw materials.

STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS 

The key players engaged in global wound healing manufacturing are making improvements to keep the speed during COVID-19. They are taking every single choice cautiously to expand on a consistent schedule for the market. The manufacturers are likewise giving a great deal of consideration in improving inventive items that can be utilized for the attractive impacts. Organizations working in the minimally invasive gastrointestinal surgical systems market embrace a few systems, including joint effort, arrangements, association, and market development, to improve their business. These essential choices by the organizations must give huge occasions to the market players working in the minimally invasive gastrointestinal surgical systems market.

For instance,

  • In October 2019, Erchonia continued to be the pioneer in developing new FDA indications for laser therapy; previously, violet light was exclusively used on dermatological conditions, which is acne. This FDA indication has enabled the company to flourish further in the market and helps in revenue generation

Conclusion

Numerous clinical trials are underway, such as photobiomodulation laser therapy for COVID-19 positive patients with pulmonary disease

LLT has been used in pain management for years and is also known as cold laser therapy, which uses low-frequency continuous laser of typically 600 to 1000 nm wavelength for pain reduction and healing stimulation. Local manufacturers are now adopting new and better characteristics to create enormous supply measures to address the issue in coming fates and also, the government is also helping to defeat all the difficulties faced in these unprecedented times. It is estimated that the COVID-19 pandemic outbreak has a negative impact on the growth of the global cold laser therapy market.

The growing prevalence of chronic diseases has necessitated the need for a stable healthcare network and adequate emergency medical services (EMS). However, certain challenges in Research and Development, high cost of the devices may hamper the market growth.

The sales of cold laser therapy products and related goods by entities (organizations, sole traders and partnerships) that offers cold laser therapy products, which aids in improving various medical condition such as sprains, inflammation, aches and pains, to furnish timely medical or surgical treatment of a condition before or after birth.

Moreover, the wider adoption of these systems is expected to increase to meet the rising demand for cold laser therapy across the globe and overcome the shortage of healthcare professionals to perform such therapies. In the wake of the pandemic, current industry players with a substantial market share that consumed cash-rich and good management teams would prosper. Making the correct actions would enable businesses to demonstrate preparation and offer end-users reliability.